These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33735065)

  • 21. Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy.
    Musumeci MB; Russo D; Limite LR; Canepa M; Tini G; Casenghi M; Francia P; Adduci C; Pagannone E; Magrì D; Volpe M; Autore C
    Am J Cardiol; 2018 Dec; 122(11):1924-1931. PubMed ID: 30293658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.
    Urbano-Moral JA; Gonzalez-Gonzalez AM; Maldonado G; Gutierrez-Garcia-Moreno L; Vivancos-Delgado R; De Mora-Martin M; Rodriguez-Palomares JF; Evangelista-Masip A
    J Am Soc Echocardiogr; 2020 Sep; 33(9):1106-1115. PubMed ID: 32564979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning.
    Davies RH; Augusto JB; Bhuva A; Xue H; Treibel TA; Ye Y; Hughes RK; Bai W; Lau C; Shiwani H; Fontana M; Kozor R; Herrey A; Lopes LR; Maestrini V; Rosmini S; Petersen SE; Kellman P; Rueckert D; Greenwood JP; Captur G; Manisty C; Schelbert E; Moon JC
    J Cardiovasc Magn Reson; 2022 Mar; 24(1):16. PubMed ID: 35272664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score.
    Todiere G; Nugara C; Gentile G; Negri F; Bianco F; Falletta C; Novo G; Di Bella G; De Caterina R; Zachara E; Re F; Clemenza F; Sinagra G; Emdin M; Aquaro GD
    Am J Cardiol; 2019 Oct; 124(8):1286-1292. PubMed ID: 31447011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry.
    Lipshultz SE; Orav EJ; Wilkinson JD; Towbin JA; Messere JE; Lowe AM; Sleeper LA; Cox GF; Hsu DT; Canter CE; Hunter JA; Colan SD;
    Lancet; 2013 Dec; 382(9908):1889-97. PubMed ID: 24011547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between ventricular filling patterns and the extent of late enhancement on magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    De Zan M; Carrascosa P; Deviggiano A; Capunay C; Rodríguez-Granillo GA
    Radiologia; 2017; 59(1):56-63. PubMed ID: 27720181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of right ventricular early diastolic filling by cine nuclear magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Suzuki J; Chang JM; Caputo GR; Higgins CB
    J Am Coll Cardiol; 1991 Jul; 18(1):120-6. PubMed ID: 2050914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.
    Rodriguez-Granillo GA; Deviggiano A; Capunay C; Zan MC; Carrascosa P
    Arq Bras Cardiol; 2016 Jul; 107(1):48-54. PubMed ID: 27305110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of papillary muscles and trabeculae on left ventricular measurement using cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Park EA; Lee W; Kim HK; Chung JW
    Korean J Radiol; 2015; 16(1):4-12. PubMed ID: 25598670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
    Brown ML; Schaff HV; Dearani JA; Li Z; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):439-43. PubMed ID: 20832083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the thickness of the right ventricular free wall by magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Suzuki J; Sakamoto T; Takenaka K; Kawakubo K; Amano K; Takahashi H; Hasegawa I; Shiota T; Hada Y; Sugimoto T
    Br Heart J; 1988 Nov; 60(5):440-5. PubMed ID: 3203039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging of apical hypertrophic cardiomyopathy.
    Soler R; Rodríguez E; Rodríguez JA; Pérez ML; Penas M
    J Thorac Imaging; 1997 Jul; 12(3):221-5. PubMed ID: 9249682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.
    Kramer CM; Appelbaum E; Desai MY; Desvigne-Nickens P; DiMarco JP; Friedrich MG; Geller N; Heckler S; Ho CY; Jerosch-Herold M; Ivey EA; Keleti J; Kim DY; Kolm P; Kwong RY; Maron MS; Schulz-Menger J; Piechnik S; Watkins H; Weintraub WS; Wu P; Neubauer S
    Am Heart J; 2015 Aug; 170(2):223-30. PubMed ID: 26299218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy.
    Badran HM; Soltan G; Almeleigi R; Faheem N; Yacoub MH
    Echocardiography; 2019 Dec; 36(12):2167-2175. PubMed ID: 31742769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging.
    Maier SE; Fischer SE; McKinnon GC; Hess OM; Krayenbuehl HP; Boesiger P
    Circulation; 1992 Dec; 86(6):1919-28. PubMed ID: 1451263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging.
    Romano R; Losi MA; Migliore T; Contaldi C; Parrella LS; Caputi A; Betocchi S
    Minerva Cardioangiol; 2008 Apr; 56(2):181-7. PubMed ID: 18319696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of cardiac dimensions in children diagnosed with hypertrophic cardiomyopathy.
    Bakaya K; Paracha W; Schievano S; Bozkurt S
    Echocardiography; 2022 Sep; 39(9):1233-1239. PubMed ID: 35978451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.